• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺髓样癌的预后因素]

[Prognostic factors in medullary breast cancer].

作者信息

Mitze M, Goepel E

机构信息

Universitäts-Frauenklinik Hamburg-Eppendorf.

出版信息

Geburtshilfe Frauenheilkd. 1989 Jul;49(7):635-41. doi: 10.1055/s-2008-1026669.

DOI:10.1055/s-2008-1026669
PMID:2777051
Abstract

In 55 patients with medullary carcinoma of the breast follow-up data over an average period of 68.1 +/- 35.3 months were recorded. The histological slides of all tumors were retrospectively classified according to the same criteria. The parameters registered were: tumor-size, histological grading, receptor status, necrosis of tumor tissue, cellularity of the stroma, status of axillary nodes, reactive changes of axillary nodes and tumor invasion of lymphatic vessels. The importance of each parameter registered for disease-free survival and overall survival was calculated statistically using the log-rank-test. Of all parameters, only the nodal status of the axilla proved prognostically significant. Metastases of axillary nodes were demonstrable in only 31% of all MC. The incidence of nodal involvement proved to be less than in non medullary breast cancers. In 15 (27.3%) of the patients, progression of the tumor occurred. All women with distant metastases i.e. 12 (21.8%) died of the disease, whereas patients with only local recurrence of breast cancer are still alive. 72.7% of the patients showed relapse-free survival. Other parameters of proven prognostic value in breast cancers like receptor status and histological grading were of no relevance to the survival in MC. Prediction of prognosis depends on the correct classification of the tumor subgroup according to strict microscopical and macroscopical criteria.

摘要

对55例乳腺髓样癌患者进行了平均68.1±35.3个月的随访数据记录。所有肿瘤的组织学切片均根据相同标准进行回顾性分类。记录的参数包括:肿瘤大小、组织学分级、受体状态、肿瘤组织坏死、间质细胞密度、腋窝淋巴结状态、腋窝淋巴结反应性改变以及肿瘤对淋巴管的侵犯。使用对数秩检验对记录的每个参数对无病生存期和总生存期的重要性进行统计学计算。在所有参数中,只有腋窝淋巴结状态具有预后意义。在所有乳腺髓样癌中,只有31%可发现腋窝淋巴结转移。淋巴结受累的发生率低于非髓样乳腺癌。15例(27.3%)患者出现肿瘤进展。所有发生远处转移的女性,即12例(21.8%)死于该疾病,而仅出现乳腺癌局部复发的患者仍然存活。72.7%的患者无复发生存。乳腺癌中其他已证实具有预后价值的参数,如受体状态和组织学分级,与乳腺髓样癌的生存无关。预后的预测取决于根据严格的微观和宏观标准对肿瘤亚组进行正确分类。

相似文献

1
[Prognostic factors in medullary breast cancer].[乳腺髓样癌的预后因素]
Geburtshilfe Frauenheilkd. 1989 Jul;49(7):635-41. doi: 10.1055/s-2008-1026669.
2
[Cathepsin D in primary breast cancer in correlation with various prognostic factors].[原发性乳腺癌中的组织蛋白酶D与各种预后因素的相关性]
Geburtshilfe Frauenheilkd. 1991 Apr;51(4):272-5. doi: 10.1055/s-2007-1023718.
3
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.LEA-135表达:其与淋巴结阳性原发性浸润性乳腺癌患者较低的复发风险及总生存期延长的相关性。
Anticancer Res. 2004 Jul-Aug;24(4):2391-400.
4
[Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer].
Geburtshilfe Frauenheilkd. 1989 Feb;49 Suppl 1:104-8. doi: 10.1055/s-2008-1026589.
5
[Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].[激素受体作为乳腺癌预后因素的意义的长期研究]
Geburtshilfe Frauenheilkd. 1990 Jul;50(7):528-32. doi: 10.1055/s-2008-1026295.
6
Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.新辅助化疗的临床和病理反应与局部晚期乳腺癌预后的关系
J Surg Oncol. 2002 May;80(1):4-11. doi: 10.1002/jso.10090.
7
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.腋窝淋巴结转移阳性率可预测非转移性乳腺癌患者的生存率。
Acta Oncol. 2008;47(2):232-8. doi: 10.1080/02841860701678761.
8
[The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].[组织蛋白酶D浓度在原发性乳腺癌细胞溶质中的预后价值]
Zentralbl Gynakol. 1995;117(5):253-9.
9
[Special clinical and follow-up aspects of invasive lobular breast cancer].[浸润性小叶癌的特殊临床及随访方面]
Geburtshilfe Frauenheilkd. 1991 Dec;51(12):973-9. doi: 10.1055/s-2008-1026247.
10
[Follow-up of 551 patients with node-negative breast cancer].
Geburtshilfe Frauenheilkd. 1992 Aug;52(8):454-61. doi: 10.1055/s-2007-1023788.